📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda. (2023)

First Author: Man-Lik Choi E

Attributed to: The impact of maternal infection with Mycobacterium tuberculosis on the infant response to BCG immunisation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2023.10.055

PubMed Identifier: 37981473

Publication URI: http://europepmc.org/abstract/MED/37981473

Type: Journal Article/Review

Volume: 41

Parent Publication: Vaccine

Issue: 50

ISSN: 0264-410X